APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxychloroquine for COVID-19

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hydroxychloroquine for COVID-19 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025196 pages

Choose your research edition.

Industry ResearchHydroxychloroquine for COVID-19 Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxychloroquine for COVID-19 Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Hydroxychloroquine for COVID-19 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxychloroquine for COVID-19 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxychloroquine for COVID-19 Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Hydroxychloroquine for COVID-19 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hydroxychloroquine for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydroxychloroquine for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxychloroquine for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hydroxychloroquine for COVID-19 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxychloroquine for COVID-19 include Advanz Pharma, Apotex, Bristol Laboratories, Hanlim Pharmaceutical, Ipca Laboratories, Kyung Poong, Sun Pharma, Zydus Cadila and Mylan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydroxychloroquine for COVID-19 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydroxychloroquine for COVID-19 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxychloroquine for COVID-19 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxychloroquine for COVID-19 market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxychloroquine for COVID-19 Segment by Company

Advanz Pharma

Apotex

Bristol Laboratories

Hanlim Pharmaceutical

Ipca Laboratories

Kyung Poong

Sun Pharma

Zydus Cadila

Mylan

Novartis

Sanofi

Shanghai Zhongxisanwei

Teva

Hydroxychloroquine for COVID-19 Segment by Type

Tablet

Injection

Hydroxychloroquine for COVID-19 Segment by Application

Mild Symptom Patient

Critically Ill Patient

Hydroxychloroquine for COVID-19 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine for COVID-19 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine for COVID-19 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine for COVID-19.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxychloroquine for COVID-19 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxychloroquine for COVID-19 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydroxychloroquine for COVID-19 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydroxychloroquine for COVID-19 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydroxychloroquine for COVID-19 Industry Trends Table 2. Hydroxychloroquine for COVID-19 Industry Drivers Table 3. Hydroxychloroquine for COVID-19 Industry Opportunities and Challenges Table 4. Hydroxychloroquine for COVID-19 Industry Restraints Table 5. Global Hydroxychloroquine for COVID-19 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydroxychloroquine for COVID-19 Sales by Manufacturers (Tons) & (2021-2026) Table 8. Global Hydroxychloroquine for COVID-19 Sales Market Share by Manufacturers Table 9. Global Hydroxychloroquine for COVID-19 Average Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Hydroxychloroquine for COVID-19 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydroxychloroquine for COVID-19 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydroxychloroquine for COVID-19 Manufacturers, Product Type & Application Table 13. Global Hydroxychloroquine for COVID-19 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxychloroquine for COVID-19 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Tablet Table 17. Major Manufacturers of Injection Table 18. Global Hydroxychloroquine for COVID-19 Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 19. Global Hydroxychloroquine for COVID-19 Sales by Type (2021-2026) & (Tons) Table 20. Global Hydroxychloroquine for COVID-19 Sales by Type (2027-2032) & (Tons) Table 21. Global Hydroxychloroquine for COVID-19 Sales Market Share by Type (2021-2026) Table 22. Global Hydroxychloroquine for COVID-19 Sales Market Share by Type (2027-2032) Table 23. Global Hydroxychloroquine for COVID-19 Revenue by Type 2021 VS 2025 VS 2032 (Tons) Table 24. Global Hydroxychloroquine for COVID-19 Revenue by Type (2021-2026) & (Tons) Table 25. Global Hydroxychloroquine for COVID-19 Revenue by Type (2027-2032) & (Tons) Table 26. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Type (2021-2026) Table 27. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Mild Symptom Patient Table 29. Major Manufacturers of Critically Ill Patient Table 30. Global Hydroxychloroquine for COVID-19 Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 31. Global Hydroxychloroquine for COVID-19 Sales by Application (2021-2026) & (Tons) Table 32. Global Hydroxychloroquine for COVID-19 Sales by Application (2027-2032) & (Tons) Table 33. Global Hydroxychloroquine for COVID-19 Sales Market Share by Application (2021-2026) Table 34. Global Hydroxychloroquine for COVID-19 Sales Market Share by Application (2027-2032) Table 35. Global Hydroxychloroquine for COVID-19 Revenue by Application 2021 VS 2025 VS 2032 (Tons) Table 36. Global Hydroxychloroquine for COVID-19 Revenue by Application (2021-2026) & (Tons) Table 37. Global Hydroxychloroquine for COVID-19 Revenue by Application (2027-2032) & (Tons) Table 38. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Application (2021-2026) Table 39. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Application (2027-2032) Table 40. Global Hydroxychloroquine for COVID-19 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 41. Global Hydroxychloroquine for COVID-19 Sales by Region (2021-2026) & (Tons) Table 42. Global Hydroxychloroquine for COVID-19 Sales Market Share by Region (2021-2026) Table 43. Global Hydroxychloroquine for COVID-19 Sales Forecasted by Region (2027-2032) & (Tons) Table 44. Global Hydroxychloroquine for COVID-19 Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 46. North America Hydroxychloroquine for COVID-19 Sales by Country (2021-2026) & (Tons) Table 47. North America Hydroxychloroquine for COVID-19 Sales by Country (2027-2032) & (Tons) Table 48. Europe Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 49. Europe Hydroxychloroquine for COVID-19 Sales by Country (2021-2026) & (Tons) Table 50. Europe Hydroxychloroquine for COVID-19 Sales by Country (2027-2032) & (Tons) Table 51. Asia Pacific Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 52. Asia Pacific Hydroxychloroquine for COVID-19 Sales by Country (2021-2026) & (Tons) Table 53. Asia Pacific Hydroxychloroquine for COVID-19 Sales by Country (2027-2032) & (Tons) Table 54. South America, Middle East and Africa Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 55. South America, Middle East and Africa Hydroxychloroquine for COVID-19 Sales by Country (2021-2026) & (Tons) Table 56. South America, Middle East and Africa Hydroxychloroquine for COVID-19 Sales by Country (2027-2032) & (Tons) Table 57. Global Hydroxychloroquine for COVID-19 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Hydroxychloroquine for COVID-19 Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Hydroxychloroquine for COVID-19 Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Region (2021-2026) Table 61. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Region (2027-2032) Table 62. Advanz Pharma Company Information Table 63. Advanz Pharma Business Overview Table 64. Advanz Pharma Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Advanz Pharma Hydroxychloroquine for COVID-19 Product Portfolio Table 66. Advanz Pharma Recent Development Table 67. Apotex Company Information Table 68. Apotex Business Overview Table 69. Apotex Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Apotex Hydroxychloroquine for COVID-19 Product Portfolio Table 71. Apotex Recent Development Table 72. Bristol Laboratories Company Information Table 73. Bristol Laboratories Business Overview Table 74. Bristol Laboratories Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Bristol Laboratories Hydroxychloroquine for COVID-19 Product Portfolio Table 76. Bristol Laboratories Recent Development Table 77. Hanlim Pharmaceutical Company Information Table 78. Hanlim Pharmaceutical Business Overview Table 79. Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Product Portfolio Table 81. Hanlim Pharmaceutical Recent Development Table 82. Ipca Laboratories Company Information Table 83. Ipca Laboratories Business Overview Table 84. Ipca Laboratories Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Ipca Laboratories Hydroxychloroquine for COVID-19 Product Portfolio Table 86. Ipca Laboratories Recent Development Table 87. Kyung Poong Company Information Table 88. Kyung Poong Business Overview Table 89. Kyung Poong Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Kyung Poong Hydroxychloroquine for COVID-19 Product Portfolio Table 91. Kyung Poong Recent Development Table 92. Sun Pharma Company Information Table 93. Sun Pharma Business Overview Table 94. Sun Pharma Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Sun Pharma Hydroxychloroquine for COVID-19 Product Portfolio Table 96. Sun Pharma Recent Development Table 97. Zydus Cadila Company Information Table 98. Zydus Cadila Business Overview Table 99. Zydus Cadila Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Zydus Cadila Hydroxychloroquine for COVID-19 Product Portfolio Table 101. Zydus Cadila Recent Development Table 102. Mylan Company Information Table 103. Mylan Business Overview Table 104. Mylan Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Mylan Hydroxychloroquine for COVID-19 Product Portfolio Table 106. Mylan Recent Development Table 107. Novartis Company Information Table 108. Novartis Business Overview Table 109. Novartis Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Novartis Hydroxychloroquine for COVID-19 Product Portfolio Table 111. Novartis Recent Development Table 112. Sanofi Company Information Table 113. Sanofi Business Overview Table 114. Sanofi Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Sanofi Hydroxychloroquine for COVID-19 Product Portfolio Table 116. Sanofi Recent Development Table 117. Shanghai Zhongxisanwei Company Information Table 118. Shanghai Zhongxisanwei Business Overview Table 119. Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Product Portfolio Table 121. Shanghai Zhongxisanwei Recent Development Table 122. Teva Company Information Table 123. Teva Business Overview Table 124. Teva Hydroxychloroquine for COVID-19 Sales (Tons), Price (US$/Ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Teva Hydroxychloroquine for COVID-19 Product Portfolio Table 126. Teva Recent Development Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Hydroxychloroquine for COVID-19 Distributors List Table 130. Hydroxychloroquine for COVID-19 Customers List Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Hydroxychloroquine for COVID-19 Product Image Figure 2. Global Hydroxychloroquine for COVID-19 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxychloroquine for COVID-19 Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxychloroquine for COVID-19 Sales (2021-2032) & (Tons) Figure 5. Global Hydroxychloroquine for COVID-19 Average Price (US$/Ton) & (2021-2032) Figure 6. Global Top 5 and 10 Hydroxychloroquine for COVID-19 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Tablet Image Figure 9. Injection Image Figure 10. Global Hydroxychloroquine for COVID-19 Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 11. Global Hydroxychloroquine for COVID-19 Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Hydroxychloroquine for COVID-19 Sales Market Share by Type (2021-2032) Figure 13. Global Hydroxychloroquine for COVID-19 Revenue by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Hydroxychloroquine for COVID-19 Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Type (2021-2032) Figure 16. Mild Symptom Patient Image Figure 17. Critically Ill Patient Image Figure 18. Global Hydroxychloroquine for COVID-19 Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 19. Global Hydroxychloroquine for COVID-19 Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Hydroxychloroquine for COVID-19 Sales Market Share by Application (2021-2032) Figure 21. Global Hydroxychloroquine for COVID-19 Revenue by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Hydroxychloroquine for COVID-19 Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Application (2021-2032) Figure 24. North America Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 25. North America Hydroxychloroquine for COVID-19 Sales Market Share by Country (2021-2032) Figure 26. U.S. Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 27. Canada Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 28. Mexico Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 29. Europe Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 30. Europe Hydroxychloroquine for COVID-19 Sales Market Share by Country (2021-2032) Figure 31. Germany Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 32. France Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 33. U.K. Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 34. Italy Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 35. Netherlands Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 36. Asia Pacific Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 37. Asia Pacific Hydroxychloroquine for COVID-19 Sales Market Share by Country (2021-2032) Figure 38. China Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 39. Japan Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 40. South Korea Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 41. Southeast Asia Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 42. India Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 43. Australia Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 44. South America, Middle East and Africa Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 45. South America, Middle East and Africa Hydroxychloroquine for COVID-19 Sales Market Share by Country (2021-2032) Figure 46. Brazil Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 47. South Africa Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 48. Saudi Arabia Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 49. Turkey Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 50. Argentina Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 51. UAE Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 52. Egypt Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 53. Chile Hydroxychloroquine for COVID-19 Sales and Growth Rate (2021-2032) & (Tons) Figure 54. Global Hydroxychloroquine for COVID-19 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Hydroxychloroquine for COVID-19 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Hydroxychloroquine for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 57. North America Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Hydroxychloroquine for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 59. Europe Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Hydroxychloroquine for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Hydroxychloroquine for COVID-19 Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Hydroxychloroquine for COVID-19 Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Hydroxychloroquine for COVID-19 Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Tablet
  • Injection
Applications
  • Mild Symptom Patient
  • Critically Ill Patient
Companies covered
  • Advanz Pharma
  • Apotex
  • Bristol Laboratories
  • Hanlim Pharmaceutical
  • Ipca Laboratories
  • Kyung Poong
  • Sun Pharma
  • Zydus Cadila
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Zhongxisanwei
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydroxychloroquine for COVID-19 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydroxychloroquine for COVID-19 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydroxychloroquine for COVID-19 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydroxychloroquine for COVID-19 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydroxychloroquine for COVID-19 Market Dynamics
  1. 2.1 Hydroxychloroquine for COVID-19 Industry Trends
  2. 2.2 Hydroxychloroquine for COVID-19 Industry Drivers
  3. 2.3 Hydroxychloroquine for COVID-19 Industry Opportunities and Challenges
  4. 2.4 Hydroxychloroquine for COVID-19 Industry Restraints
3 Hydroxychloroquine for COVID-19 Market by Manufacturers
  1. 3.1 Global Hydroxychloroquine for COVID-19 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydroxychloroquine for COVID-19 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydroxychloroquine for COVID-19 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydroxychloroquine for COVID-19 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxychloroquine for COVID-19 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydroxychloroquine for COVID-19 Manufacturers, Product Type & Application
  7. 3.7 Global Hydroxychloroquine for COVID-19 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxychloroquine for COVID-19 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxychloroquine for COVID-19 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxychloroquine for COVID-19 Tier 1, Tier 2, and Tier 3
4 Hydroxychloroquine for COVID-19 Market by Type
  1. 4.1 Hydroxychloroquine for COVID-19 Type Introduction
  2. 4.1.1 Tablet
  3. 4.1.2 Injection
  4. 4.2 Global Hydroxychloroquine for COVID-19 Sales by Type
  5. 4.2.1 Global Hydroxychloroquine for COVID-19 Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Hydroxychloroquine for COVID-19 Sales by Type (2021-2032)
  7. 4.2.3 Global Hydroxychloroquine for COVID-19 Sales Market Share by Type (2021-2032)
  8. 4.3 Global Hydroxychloroquine for COVID-19 Revenue by Type
  9. 4.3.1 Global Hydroxychloroquine for COVID-19 Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Hydroxychloroquine for COVID-19 Revenue by Type (2021-2032)
  11. 4.3.3 Global Hydroxychloroquine for COVID-19 Revenue Market Share by Type (2021-2032)
5 Hydroxychloroquine for COVID-19 Market by Application
  1. 5.1 Hydroxychloroquine for COVID-19 Application Introduction
  2. 5.1.1 Mild Symptom Patient
  3. 5.1.2 Critically Ill Patient
  4. 5.2 Global Hydroxychloroquine for COVID-19 Sales by Application
  5. 5.2.1 Global Hydroxychloroquine for COVID-19 Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Hydroxychloroquine for COVID-19 Sales by Application (2021-2032)
  7. 5.2.3 Global Hydroxychloroquine for COVID-19 Sales Market Share by Application (2021-2032)
  8. 5.3 Global Hydroxychloroquine for COVID-19 Revenue by Application
  9. 5.3.1 Global Hydroxychloroquine for COVID-19 Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Hydroxychloroquine for COVID-19 Revenue by Application (2021-2032)
  11. 5.3.3 Global Hydroxychloroquine for COVID-19 Revenue Market Share by Application (2021-2032)
6 Global Hydroxychloroquine for COVID-19 Sales by Region
  1. 6.1 Global Hydroxychloroquine for COVID-19 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxychloroquine for COVID-19 Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxychloroquine for COVID-19 Sales by Region (2021-2026)
  4. 6.2.2 Global Hydroxychloroquine for COVID-19 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydroxychloroquine for COVID-19 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydroxychloroquine for COVID-19 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydroxychloroquine for COVID-19 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydroxychloroquine for COVID-19 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydroxychloroquine for COVID-19 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydroxychloroquine for COVID-19 Revenue by Region
  1. 7.1 Global Hydroxychloroquine for COVID-19 Revenue by Region
  2. 7.1.1 Global Hydroxychloroquine for COVID-19 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydroxychloroquine for COVID-19 Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydroxychloroquine for COVID-19 Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydroxychloroquine for COVID-19 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydroxychloroquine for COVID-19 Revenue (2021-2032)
  8. 7.2.2 North America Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydroxychloroquine for COVID-19 Revenue (2021-2032)
  11. 7.3.2 Europe Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydroxychloroquine for COVID-19 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydroxychloroquine for COVID-19 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydroxychloroquine for COVID-19 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Advanz Pharma
  2. 8.1.1 Advanz Pharma Company Information
  3. 8.1.2 Advanz Pharma Business Overview
  4. 8.1.3 Advanz Pharma Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Advanz Pharma Hydroxychloroquine for COVID-19 Product Portfolio
  6. 8.1.5 Advanz Pharma Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Hydroxychloroquine for COVID-19 Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 Bristol Laboratories
  14. 8.3.1 Bristol Laboratories Company Information
  15. 8.3.2 Bristol Laboratories Business Overview
  16. 8.3.3 Bristol Laboratories Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bristol Laboratories Hydroxychloroquine for COVID-19 Product Portfolio
  18. 8.3.5 Bristol Laboratories Recent Developments
  19. 8.4 Hanlim Pharmaceutical
  20. 8.4.1 Hanlim Pharmaceutical Company Information
  21. 8.4.2 Hanlim Pharmaceutical Business Overview
  22. 8.4.3 Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Hanlim Pharmaceutical Hydroxychloroquine for COVID-19 Product Portfolio
  24. 8.4.5 Hanlim Pharmaceutical Recent Developments
  25. 8.5 Ipca Laboratories
  26. 8.5.1 Ipca Laboratories Company Information
  27. 8.5.2 Ipca Laboratories Business Overview
  28. 8.5.3 Ipca Laboratories Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Ipca Laboratories Hydroxychloroquine for COVID-19 Product Portfolio
  30. 8.5.5 Ipca Laboratories Recent Developments
  31. 8.6 Kyung Poong
  32. 8.6.1 Kyung Poong Company Information
  33. 8.6.2 Kyung Poong Business Overview
  34. 8.6.3 Kyung Poong Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kyung Poong Hydroxychloroquine for COVID-19 Product Portfolio
  36. 8.6.5 Kyung Poong Recent Developments
  37. 8.7 Sun Pharma
  38. 8.7.1 Sun Pharma Company Information
  39. 8.7.2 Sun Pharma Business Overview
  40. 8.7.3 Sun Pharma Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sun Pharma Hydroxychloroquine for COVID-19 Product Portfolio
  42. 8.7.5 Sun Pharma Recent Developments
  43. 8.8 Zydus Cadila
  44. 8.8.1 Zydus Cadila Company Information
  45. 8.8.2 Zydus Cadila Business Overview
  46. 8.8.3 Zydus Cadila Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Zydus Cadila Hydroxychloroquine for COVID-19 Product Portfolio
  48. 8.8.5 Zydus Cadila Recent Developments
  49. 8.9 Mylan
  50. 8.9.1 Mylan Company Information
  51. 8.9.2 Mylan Business Overview
  52. 8.9.3 Mylan Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mylan Hydroxychloroquine for COVID-19 Product Portfolio
  54. 8.9.5 Mylan Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Hydroxychloroquine for COVID-19 Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Sanofi
  62. 8.11.1 Sanofi Company Information
  63. 8.11.2 Sanofi Business Overview
  64. 8.11.3 Sanofi Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sanofi Hydroxychloroquine for COVID-19 Product Portfolio
  66. 8.11.5 Sanofi Recent Developments
  67. 8.12 Shanghai Zhongxisanwei
  68. 8.12.1 Shanghai Zhongxisanwei Company Information
  69. 8.12.2 Shanghai Zhongxisanwei Business Overview
  70. 8.12.3 Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Shanghai Zhongxisanwei Hydroxychloroquine for COVID-19 Product Portfolio
  72. 8.12.5 Shanghai Zhongxisanwei Recent Developments
  73. 8.13 Teva
  74. 8.13.1 Teva Company Information
  75. 8.13.2 Teva Business Overview
  76. 8.13.3 Teva Hydroxychloroquine for COVID-19 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Teva Hydroxychloroquine for COVID-19 Product Portfolio
  78. 8.13.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxychloroquine for COVID-19 Value Chain Analysis
  2. 9.1.1 Hydroxychloroquine for COVID-19 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxychloroquine for COVID-19 Production Mode & Process
  6. 9.2 Hydroxychloroquine for COVID-19 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxychloroquine for COVID-19 Distributors
  9. 9.2.3 Hydroxychloroquine for COVID-19 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst